This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Email citation

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 1992:61:139-60.

doi: 10.1007/978-1-4615-3500-3_7.

Mechanisms involving an expanding erbB/EGF receptor family of tyrosine kinases in human neoplasia

P P Di Fiore, M H Kraus

PMID: 1360229
DOI: 10.1007/978-1-4615-3500-3_7

Review

Mechanisms involving an expanding erbB/EGF receptor family of tyrosine kinases in human neoplasia

P P Di Fiore et al. Cancer Treat Res. 1992.

. 1992:61:139-60.

doi: 10.1007/978-1-4615-3500-3_7.

Authors

P P Di Fiore, M H Kraus

PMID: 1360229
DOI: 10.1007/978-1-4615-3500-3_7

No abstract available

PubMed Disclaimer

Similar articles

A chimeric EGFR/neu receptor in studies of neu function.
Lehtola L, Lehväslaiho H, Koskinen P, Alitalo K. Lehtola L, et al. Cancer Treat Res. 1992;61:213-28. doi: 10.1007/978-1-4615-3500-3_11. Cancer Treat Res. 1992. PMID: 1360234 Review. No abstract available.
A chimeric EGF-R-neu proto-oncogene allows EGF to regulate neu tyrosine kinase and cell transformation.
Lehväslaiho H, Lehtola L, Sistonen L, Alitalo K. Lehväslaiho H, et al. EMBO J. 1989 Jan;8(1):159-66. doi: 10.1002/j.1460-2075.1989.tb03360.x. EMBO J. 1989. PMID: 2565807 Free PMC article.
c-erbB2 amplification and overexpression in human tumors.
Lofts FJ, Gullick WJ. Lofts FJ, et al. Cancer Treat Res. 1992;61:161-79. Cancer Treat Res. 1992. PMID: 1360230 Review.
Tyrosine kinase activity may be necessary but is not sufficient for c-erbB1-mediated tissue-specific tumorigenicity.
Connolly DC, Toutenhoofd SL, Maihle NJ. Connolly DC, et al. J Virol. 1994 Oct;68(10):6804-10. doi: 10.1128/JVI.68.10.6804-6810.1994. J Virol. 1994. PMID: 7916062 Free PMC article.
Clinical significance of erbB2 protein overexpression.
Paik S, Burkhard E, Lippman ME. Paik S, et al. Cancer Treat Res. 1992;61:181-91. doi: 10.1007/978-1-4615-3500-3_9. Cancer Treat Res. 1992. PMID: 1360231 Review. No abstract available.

See all similar articles

Cited by

eps15, a novel tyrosine kinase substrate, exhibits transforming activity.
Fazioli F, Minichiello L, Matoskova B, Wong WT, Di Fiore PP. Fazioli F, et al. Mol Cell Biol. 1993 Sep;13(9):5814-28. doi: 10.1128/mcb.13.9.5814-5828.1993. Mol Cell Biol. 1993. PMID: 7689153 Free PMC article.
Increased erbB3 promotes erbB2/neu-driven mammary tumor proliferation and co-targeting of erbB2/erbB3 receptors exhibits potent inhibitory effects on breast cancer cells.
Lyu H, Huang J, Edgerton SM, Thor AD, He Z, Liu B. Lyu H, et al. Int J Clin Exp Pathol. 2015 Jun 1;8(6):6143-56. eCollection 2015. Int J Clin Exp Pathol. 2015. PMID: 26261492 Free PMC article.
Identification of ErbB3-stimulated genes using modified representational difference analysis.
Edman CF, Prigent SA, Schipper A, Feramisco JR. Edman CF, et al. Biochem J. 1997 Apr 1;323 ( Pt 1)(Pt 1):113-8. doi: 10.1042/bj3230113. Biochem J. 1997. PMID: 9173868 Free PMC article.

Publication types

Actions

MeSH terms

Substances

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Other Literature Sources
- The Lens - Patent Citations Database
Research Materials
- NCI CPTC Antibody Characterization Program
Miscellaneous
- NCI CPTAC Assay Portal